Short answer
Neuronetics, Inc. (STIM) filed its Q3 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $42M (up 12.5% year over year) with net income of −$2M.
Q3 2026 key financials · XBRL
- Revenue
- $42M
- +12.5% YoY · +0.9% QoQ
- Net income
- −$2M
- +81.3% YoY · +50.8% QoQ
- Operating margin
- 1.3%
- Gross margin
- 52.2%
- EPS (diluted)
- −$0.02
- +84.6% YoY · +50.0% QoQ
Source: XBRL data from the Neuronetics, Inc. (STIM) Q3 2026 10-Q on SEC EDGAR. USD.
Neuronetics, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $42.0M, up 13% YoY from $37.3M
- Gross margin 52.2% vs 45.9% YoY, net loss $1.6M vs $9.4M
- Best segment Greenbrook revenue $26.2M, up 20%; NeuroStar $15.8M, up $0.3M
- Cash $22.1M vs $28.1M at December 31; nine-month operating cash outflow $9.2M
- March 31, 2027 revenue covenant risk, substantial doubt about going concern despite lender discussions
Risk Factors
- No material changes identified from the March 17, 2026 Form 10-K and May 5, 2026 Form 10-Q
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Neuronetics, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.